The Latest in Conference Coverage

Retinal thickness a new predictor of MS disability?

July 19, 2023

Multiple Sclerosis

High-efficacy therapies for MS: When and how to use them

October 27, 2022

Multiple Sclerosis

Cognitive impairment may predict physical disability in MS

July 11, 2022

Multiple Sclerosis

Risk of drug interactions is on the rise as MS drugs evolve

June 13, 2022

Multiple Sclerosis

Consider the wider picture in relapsing remitting MS

June 13, 2022

Multiple Sclerosis

Inebilizumab beneficial across genotypes in NMOSD

June 10, 2022

Multiple Sclerosis

Stem cell transplants for MS are a ‘reasonable option,’ but questions persist

June 7, 2022

Multiple Sclerosis

MS and COVID-19: Conflicting signs on risk but some trends are clearer

June 7, 2022

Multiple Sclerosis

Non-White subjects are sparse in DMT trials for MS

June 6, 2022

Multiple Sclerosis

Neighborhood-level data sheds new light on racial and ethnic diversity in MS

April 11, 2022

Multiple Sclerosis

Keto diet in MS tied to less disability, better quality of life

April 5, 2022

Multiple Sclerosis

Early MS biomarkers may improve prediction of long-term outcomes

March 15, 2022

Multiple Sclerosis

B-cell depletion overkill?

March 14, 2022

Multiple Sclerosis

Home cognitive therapy looks feasible in MS

March 11, 2022

Multiple Sclerosis

DMTs tied to lower MS relapse during reproductive therapy

March 11, 2022

Multiple Sclerosis